Open AccessCorrection to: Efficacy and Safety of Apatinib in Patients with Recurrent or Refractory Melanoma
Publication year - 2022
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1093/oncolo/oyac103
Subject(s) - apatinib , medicine , refractory (planetary science) , safety profile , melanoma , oncology , dermatology , adverse effect , cancer research , cancer , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom